BR9405308A - Uso de um antagonista de bradicinina ou de um de seus sais fisiologicamente tolerados; preparado combinado; uso de um antagonista de bradicinina e de um outro agente antiviral, e processo para a preparação do dito preparado - Google Patents

Uso de um antagonista de bradicinina ou de um de seus sais fisiologicamente tolerados; preparado combinado; uso de um antagonista de bradicinina e de um outro agente antiviral, e processo para a preparação do dito preparado

Info

Publication number
BR9405308A
BR9405308A BR9405308A BR9405308A BR9405308A BR 9405308 A BR9405308 A BR 9405308A BR 9405308 A BR9405308 A BR 9405308A BR 9405308 A BR9405308 A BR 9405308A BR 9405308 A BR9405308 A BR 9405308A
Authority
BR
Brazil
Prior art keywords
preparation
bradykinin antagonist
preparing
physiologically tolerated
antiviral agent
Prior art date
Application number
BR9405308A
Other languages
English (en)
Inventor
Klaus Dr Wirth
Irvin Dr Winkler
Fred Dr Lembeck
Gerhard Dr Breipohl
Stephan Dr Henke
Jochen Dr Knolle
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BR9405308A publication Critical patent/BR9405308A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9405308A 1993-12-31 1994-12-29 Uso de um antagonista de bradicinina ou de um de seus sais fisiologicamente tolerados; preparado combinado; uso de um antagonista de bradicinina e de um outro agente antiviral, e processo para a preparação do dito preparado BR9405308A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4345062A DE4345062A1 (de) 1993-12-31 1993-12-31 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen

Publications (1)

Publication Number Publication Date
BR9405308A true BR9405308A (pt) 1995-09-19

Family

ID=6506576

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9405308A BR9405308A (pt) 1993-12-31 1994-12-29 Uso de um antagonista de bradicinina ou de um de seus sais fisiologicamente tolerados; preparado combinado; uso de um antagonista de bradicinina e de um outro agente antiviral, e processo para a preparação do dito preparado

Country Status (21)

Country Link
US (1) US5789383A (pt)
EP (1) EP0661058B1 (pt)
JP (1) JP3828593B2 (pt)
KR (1) KR100358822B1 (pt)
CN (1) CN1119171C (pt)
AT (1) ATE255417T1 (pt)
AU (1) AU696629B2 (pt)
BR (1) BR9405308A (pt)
CA (1) CA2138933C (pt)
DE (2) DE4345062A1 (pt)
DK (1) DK0661058T3 (pt)
ES (1) ES2211874T3 (pt)
FI (1) FI117320B (pt)
HU (1) HU226374B1 (pt)
IL (1) IL112183A (pt)
MY (1) MY112888A (pt)
NO (1) NO317660B1 (pt)
PT (1) PT661058E (pt)
RU (1) RU2228195C2 (pt)
UA (1) UA41326C2 (pt)
ZA (1) ZA9410381B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737408B1 (fr) 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
WO2016170382A1 (en) * 2015-04-23 2016-10-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions comprising a bradykinin 2 receptor antagonist for prevention or treatment of impaired skin wound healing
HRP20220479T1 (hr) 2016-06-01 2022-05-27 Athira Pharma, Inc. Spojevi

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
CZ203693A3 (en) * 1991-04-01 1994-07-13 Cortech Bradykinin antagonists
ES2123556T3 (es) * 1991-04-19 1999-01-16 Scios Nova Inc Peptidos de tipo bradiquinina.
WO1992018156A1 (en) * 1991-04-19 1992-10-29 Nova Technology Limited Partnership Bradykinin antagonist peptides
US5240694A (en) * 1991-09-23 1993-08-31 University Of Virginia Combined antiviral and antimediator treatment of common colds
RU2043115C1 (ru) * 1992-06-11 1995-09-10 Товарищество с ограниченной ответственностью "Резонанс-фарма" Средство, повышающее выживаемость и облегчающее течение вирусной инфекции - экстромелии в эксперименте
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
WO1996006083A1 (en) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists

Also Published As

Publication number Publication date
ES2211874T3 (es) 2004-07-16
FI950010L (fi) 1995-07-01
IL112183A0 (en) 1995-03-15
DE4345062A1 (de) 1995-07-13
NO317660B1 (no) 2004-11-29
KR100358822B1 (ko) 2003-01-24
RU2228195C2 (ru) 2004-05-10
CA2138933C (en) 2010-02-23
CN1108138A (zh) 1995-09-13
IL112183A (en) 2001-01-11
FI950010A0 (fi) 1995-01-02
UA41326C2 (uk) 2001-09-17
KR950016779A (ko) 1995-07-20
CN1119171C (zh) 2003-08-27
HU226374B1 (en) 2008-10-28
EP0661058A1 (de) 1995-07-05
US5789383A (en) 1998-08-04
RU94045140A (ru) 1996-10-20
AU8179194A (en) 1995-07-13
EP0661058B1 (de) 2003-12-03
AU696629B2 (en) 1998-09-17
HU9403783D0 (en) 1995-02-28
NO945094D0 (no) 1994-12-30
DE59410340D1 (de) 2004-01-15
HUT71422A (en) 1995-11-28
PT661058E (pt) 2004-04-30
MY112888A (en) 2001-10-31
JP3828593B2 (ja) 2006-10-04
JPH07206703A (ja) 1995-08-08
CA2138933A1 (en) 1995-07-01
ATE255417T1 (de) 2003-12-15
FI117320B (fi) 2006-09-15
NO945094L (no) 1995-07-03
DK0661058T3 (da) 2004-04-05
ZA9410381B (en) 1995-08-29

Similar Documents

Publication Publication Date Title
MX9200361A (es) Nuevo uso del antagonista de adenosina.
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
DK0574457T3 (da) Antiviral nucleosidkombination
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
DE69932510D1 (de) Vaskularisierungsinhibitoren
ZA913033B (en) N-(3-fluoro-2-phosphonylmethoxypropyl)derivatives of purine and pyrimidine heterocyclic basis,their preparation and use
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
FI913957A7 (fi) 6,7-dihydro-3-fenyyli-1,2-bentsisoksatsol-4(5H)-oneja ja -oleja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
PT100914A (pt) Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
DE68900760D1 (de) Virushemmende nukleosidmischung.
DK627289D0 (da) Anvendelse af bicyclononanderivater
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
EE200300506A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
NO903939L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO922437D0 (no) Terapeutisk aktive fluorsubstituerte benzimidazoler, fremgangsmaate for deres fremstilling samt deres anvendelse
SE9602262D0 (sv) New use of derivatives of cystine
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
NO920056D0 (no) Antidepresjonsmiddel
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.
DE68914809D1 (de) Antivirale Wirkstoffe.
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
PT89582B (pt) Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal
B15K Others concerning applications: alteration of classification

Ipc: A61K 38/04 (2006.01)